Inhibitor of differentiation-4 is highly expressed in glioblastoma multiforme (GBM). We report a novel proangiogenic function for inhibitor of differentiation-4 in the growth of glioblastoma xenografts. Tumor-derived cell cultures expressing elevated levels of ID4 produced enlarged xenografts in immunosuppressed mice that were better vascularized than corresponding control tumors and expressed elevated matrix GLA protein (MGP) that mediated enhanced tumor angiogenesis. Inhibition of MGP resulted in smaller and less vascularized xenografts. Our finding shows a novel function for ID4 in tumor angiogenesis, and identifies ID4 and MGP as possible therapeutic targets for GBM.
Introduction
The ID (inhibitor of DNA binding/differentiation) proteins are a family of helix-loop-helix transcription factors important in development and cell cycle control (Ruzinova and Benezra, 2003) . Typically, they are highly expressed during embryogenesis and at lower levels in mature tissues with the exception of some stem cells (Yun et al., 2004) and many cancers, including brain tumors (AndresBarquin et al., 1997; Vandeputte et al., 2002; Jeon et al., 2008) . Expression of ID family members has been associated with features of malignancies (Ruzinova and Benezra, 2003) , including cellular transformation, immortalization, enhanced proliferation, migration, invasion, metastasis, angiogenesis, and maintenance of tumor-initiating cells (Jeon et al., 2008) .
Basic helix-loop-helix transcription factors share a helix-loop-helix motif of two conserved amphipathic a-helices joined by an intervening 'loop' region and highly basic amino-acids N-terminal to the helix-loophelix motif, which interacts with DNA at the recognition sequence CANNTG in the promoter of target genes (Massari and Murre, 2000) . As ID proteins lack this basic DNA-binding domain (Benezra et al., 1990) , heterodimers containing an ID protein cannot bind DNA and the transcription of target genes is not initiated.
Expanding on past work (AndresBarquin et al., 1997; Vandeputte et al., 2002; Jeon et al., 2008) , we found ID4 elevated in glioblastoma multiforme (GBM), a highly aggressive and well-vascularized brain tumor that is refractory to existing therapies (Kleihues and Cavenee, 1997) . The difficulties in treating this tumor led us to investigate the potential function of ID4 in the pathogenesis of glioblastoma.
Results

ID4 expression is elevated in GBM
To extend the observation that ID4 may be elevated in brain tumor tissues (AndresBarquin et al., 1997) and to evaluate ID4 expression in GBM and normal brain, we examined these tissues ( Figure 1A ). We identified a low level of ID4 expression in normal brain ( Figure 1A , panel a) and higher levels in GBM, with intense nuclear staining ( Figure 1A , panel b). To quantify more precisely the levels of ID4, we used quantitative realtime polymerase chain reaction (QRT-PCR) analysis to measure mRNA levels in tumors and GBM-derived cell lines (Figures 1B and C) . Most GBM-derived cell lines expressed higher ID4 levels than normal human astrocytes, and many cell lines had levels 410-fold higher than that of normal human astrocytes ( Figure 1B) . In all tumors, ID4 levels were higher than in normal frontal cortex ( Figure 1C ). When the expression of ID4 in two representative GBM-derived cell lines (U251 and U87) was compared with that in GBM tumors, the cell lines expressed ID4 at levels 20-to 50-fold lower than most tumors ( Figure 1C ). ID4 is aberrantly elevated in GBM tumors and GBM-derived cell lines. Importantly, this elevation is significantly greater in tumor tissues than in tumor cell lines, suggesting that ID4 contributes to a function selected for during tumorigenesis.
ID4 facilitates growth of GBM xenografts
We prepared independent, stable, polyclonal cultures of GBM-derived cell lines, U251 and U87, expressing ID4 at elevated levels. These cell lines grow robustly in vitro and can grow as xenografts in immunosuppressed mice (Ozawa et al., 1998) . We transfected these with pLHCX-FLAG-ID4 or the corresponding vector plasmid. As indicated in Figures 1B and C, ID4 mRNA levels in U251 and U87 cell lines were 20-to 70-fold below that observed in human glioma specimens expressing the highest ID4 levels. The level of ID4 mRNA in our stable polyclonal cultures was B30-fold the levels in the parental cell lines (data not shown). We, therefore, believe that protein levels of ID4 in our stable cultures are likely to reflect protein levels in GBM cells appropriate for gain-of-function experiments.
To determine whether ID4 would facilitate the growth of GBM tumors in vivo, we injected stable cultures expressing ID4 at elevated levels (U251::ID4-V and U87::ID4-I) and their counterparts that express ID4 at endogenous levels (U251::vector-II and U87::vector-III) subcutaneously into the flanks of immunosuppressed mice. We examined subcutaneous rather than intracranial xenografts because our aim was to follow tumor growth, and intracranial growth in a confined space killed test animals too quickly to allow the assessment of tumor growth patterns. Once the tumors were palpable, B10 days post-injection, we assessed their size every 3-4 days (Figure 2 ). At harvest, the average size of the xenografted tumors expressing elevated ID4 was larger than controls (Figures 2a and b) .
Effect of ID4 on proliferation and apoptosis measured in vitro We examined in vitro proliferation and apoptosis in the same cell cultures used for xenografting. There was no difference in growth between the U87 cultures expressing elevated ID4 and control cultures (Supplementary Figure S1A) , and the U251 cultures expressing elevated ID4 grew slower than controls (Supplementary Figure  S1B) . These findings indicate that the enhanced growth of these xenografts could not be explained by the increased proliferative activity of the tumor cells themselves. We assessed apoptosis in these U87 and U251 cultures by flow cytometry. We calculated the number of apoptotic cells in normoxia and after 12 and 24 h in hypoxic conditions because areas of chronic hypoxia are prominent features of GBM tumors (Kleihues and Cavenee, 1997) . We observed no difference in the number of apoptotic cells in the U87-and U251-derived cell cultures that expressed varying levels of ID4 (Supplementary Figures S1C and S1D ). As ID4 did not affect in vitro proliferation or apoptosis of early passage, polyclonal, U87-, or U251-derived cell cultures, we randomly chose cultures representative of these transfectants for further study.
Media conditioned by GBM-derived cultures expressing elevated ID4 promotes proliferation and tube formation of endothelial cells ID1 and ID3 promote the growth of blood vessels in various solid tumors (Lyden et al., 1999; Benezra, 2001; Benezra et al., 2001) , suggesting a possible function for ID4 in angiogenesis. To investigate this possibility, we prepared conditioned media from cell cultures expressing different levels of ID4 and observed its effect on the migration and growth of bovine aortic endothelial cells (BAECs) and their ability to form enclosures in a collagen-I tube-formation assay, an in vitro correlate for angiogenesis (Kubota et al., 1988; Bostrom et al., 2004) .
We cultured BAECs in various conditioned media and evaluated migration using the 'scratch test,' to measure the speed with which confluent, adherent cells repopulate a small, central area of the culture dish scraped free of cells (Lampugnani, 1999) , but did not identify a function for ID4 in regulating the migration of endothelial cells (data not shown). We then assessed the proliferation of BAECs grown in media conditioned by U87::ID4-I and U251::ID4-V and found that they grew faster than the BAECs grown in control-conditioned media (Figures 3a and b) . These data suggest that tumor cells expressing high levels of ID4 may express factor(s) that support the proliferation of BAECs.
We next sought to determine whether such conditioned media could promote the formation of endothelial cell enclosures in a collagen-I tube-formation assay. We acquired photographs of BAEC enclosures that developed after treatment with media conditioned by U251::ID4-V and U251::vector-II cell cultures (Figure 3c ). BAECs grown in media conditioned by the GBM-derived cell cultures expressing elevated ID4 formed significantly more enclosures than BAECs grown in control-conditioned media (Figure 3d ).
ID4 promotes angiogenesis in GBM xenografts
Histologic examination of xenografts from GBMderived cell cultures indicated that xenografts expressing elevated ID4 levels had superficial blood vessels, which appeared more numerous and larger ( Figure 4A , upper panel) than control xenograft vessels ( Figure 4A , lower panel). These vessels occurred in an area of the tumor in which the tumor-host interface might have characteristics shared by both tumor angiogenesis and angiogenesis associated with the wound response. In contrast, the distribution, size, and quantity of the vessels at the core of the xenografts were similar in all of the tumors examined (data not shown). We, therefore, evaluated the blood vessels at the surface of the tumors to assess differences in tumor vasculature.
MECA-32 is expressed in murine endothelium of both embryonic and adult tissues (Mikkola et al., 2003) . Immunohistochemical analysis of MECA-32 in numerous U251 and U87 xenografts was consistent with our initial observation: superficial blood vessels in xenografts expressing high ID4 levels ( Figure 4B , panels a and b) were larger and more numerous than vessels in control tumors ( Figure 4B , panels c and d). To quantify these vessels, we acquired photographs of the tumor periphery recording all superficial blood vessels. These images were processed and blood vessel area calculated as described in Materials and methods and Supplementary Figure S2 . In U87 xenografts expressing high ID4 ID4 elevates MGP promoting GBM growth PM Kuzontkoski et al levels, there was approximately twice the area covered by blood vessels than in U87 control xenografts ( Figure 4C ). Similarly, when U251 xenografts were examined, there was B50% more area covered by blood vessels in tumors expressing high ID4 than in control tumors ( Figure 4C ). These data indicate that GBMderived xenografts with elevated ID4 levels are more vascularized than xenografts of their control counterparts ( Figure 4D ).
Identification of a potential ID4 target promoting angiogenesis in GBM-derived xenografts
We compared gene expression patterns of two stable U251 cultures that expressed high levels of ID4 and two comparable control cultures by microarray analysis. Control samples with endogenous ID4 levels were grouped and used as a baseline to which the samples with elevated ID4 were compared. Thirty-eight genes with assigned UniGene names and symbols were identified as differentially expressed by at least twofold. The expression of 12 genes increased at least twofold and the expression of 26 genes decreased at least twofold when ID4 was elevated (Supplementary Table S1 ). We systematically searched the literature for information about each of these genes, but the expression patterns and documented biologies associated with these genes did not suggest a function in angiogenesis, except in the case of matrix GLA protein (MGP) (St Croix et al., 2000; Bostrom et al., 2004) .
Correlation of ID4 and MGP expression in GBM-derived, polyclonal cultures
To confirm the elevated expression of MGP, as indicated by microarray analysis, we used QRT-PCR to measure MGP mRNA levels in all the U251 and U87 polyclonal cultures we derived. Cultures expressing elevated ID4 also expressed MGP levels, which were higher than those in control cultures (Figure 5a ). Linear regression analysis revealed a strong, positive correlation between ID4 and MGP (r ¼ 0.89, Po0.001) in the cultures examined (Figure 5b ). To evaluate MGP levels in GBM-derived cell cultures in which the expression of ID4 had been reduced, we used the U251 and the SW1088 cell lines, which express moderate levels of ID4 (Figure 1b) . In preliminary experiments, we found that transfection with either pRS::shID4-52, pRS::shID4-53, or pRS::shID4-55 (Origene Technologies, Inc., Rockville, MD, USA) reduced ID4 expression levels (our unpublished data) below the levels observed in control cultures created with the pRS::sh-scrambled plasmid (Origene Technologies, Inc.). To quantify ID4 and MGP mRNA, we used QRT-PCR. ID4 levels in the SW1088 stable, polyclonal cultures expressing the shID4-55 construct were reduced B60% (Figure 5c ). 
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The MGP and ID4 levels in U251 polyclonal cultures transiently expressing the shID4-52 and shID4-53 constructs were reduced B50% compared with control cultures (Figure 5d ).
ID4 mediates the growth of GBM xenografts by elevating MGP levels
To determine whether MGP expression is necessary for ID4-mediated GBM xenograft growth, we derived stable, polyclonal U251 cultures expressing elevated levels of ID4, but reduced levels of MGP (U251::ID4:: shMGP) and corresponding control cultures (U251:: ID4::sh-scrambled). We transfected U251::ID4-V with either the pRS::shMGP-14 plasmid that encodes an shRNA complementary to MGP or with a control plasmid, pRS::sh-scrambled (Origene Technologies, Inc.). MGP levels were decreased by 30-40% by shMGP-14 (Figure 6a) . To examine the effect of MGP reduction in GBMderived, stable cultures with elevated ID4 levels, we evaluated xenografts of U251::ID4::shMGP-I and U251::ID4::sh-scrambled-II cultures (Figure 6b ). The xenografts that arose from cultures with reduced MGP were significantly smaller than the control xenografts (Figure 6b ). We also examined the in vitro rates of proliferation and apoptosis of these cultures. U251::ID4::shMGP-I cultures with decreased levels of MGP grew faster than the corresponding control cultures (Supplementary Figure S3A) , and we found no difference in apoptosis (Supplementary Figure S3B) . These data do not support an effect of MGP on tumor cell proliferation or apoptosis that could explain the decreased size of the U251::ID4::shMGP-I xenografts. When we examined these tumors histologically, the only detectable difference from U251::ID4 xenografts was the extent of vascularization on the xenograft surface (data not shown). Representative sections of these xenografts, stained with MECA-32 antibody to identify the blood vessels, support this observation (Figure 6c) . We quantitated the differences in the superficial tumor vasculature in histological sections of U251::ID4::shMGP-I and U251::ID4::sh-scrambled-II xenografts. In xenograft sections with diminished levels of MGP (U251::ID4::shMGP-I), blood vessels covered approximately half of the area covered by blood vessels 
Discussion
Tumors require vasculature to support their metabolic needs (Folkman, 2002) . Tumor cells and their microenvironment use a variety of mechanisms to modulate pro-and anti-angiogenic factors in favor of angiogenesis, thereby permitting the expansion of solid tumors and facilitating metastases (Bouck et al., 1996; Bergers and Benjamin, 2003) . Destroying or inhibiting tumor vasculature has a far-reaching effect in that the disruption of a single blood vessel can compromise the viability of tumor cells well beyond those cells that are immediately proximal to the vessel (Folkman, 1971) . In this regard, identifying targets for anti-angiogenesis therapy may be of particular importance for improving the treatment of GBM, a highly vascularized, lethal, solid tumor (Folkman, 1971; Holland, 2000; Kargiotis et al., 2006) . ID family members including ID1, ID2, and ID3 have identified functions in tumor progression, including angiogenesis, invasion, and metastasis (Lyden et al., 1999; Benezra, 2001; Benezra et al., 2001; Folkman, 2002; Ruzinova and Benezra, 2003; , and in other circumstances ID1 and ID2 may function as tumor suppressors in rodents (Itahana et al., 2003; Sikder et al., 2003; Russell et al., 2004) . The function of ID4 in tumorigenesis is similarly complex (Beger et al., 2001; Bellido et al., 2003; Chan et al., 2003; Shan et al., 2003; Umetani et al., 2004 Umetani et al., , 2005 Jeon et al., 2008) . ID4 seems to function as a tumor suppressor in a variety of cancers (Chan et al., 2003; Umetani et al., 2004 Umetani et al., , 2005 Yu et al., 2005) and is downregulated by promoter hypermethylation in several tumor types (Chan et al., 2003; Umetani et al., 2004 Umetani et al., , 2005 Yu et al., 2005) . In sharp contrast, however, ID4 promotes some aspects of tumorigenesis in B-cell lineage ALL, glioblastoma, and sporadic breast and ovarian cancers (Beger et al., 2001; Bellido et al., 2003; Jeon et al., 2008) , and its expression is heightened in bladder cancer because of gene amplification .
In this study, we show elevated levels of ID4 in GBM and in GBM-derived cell lines. Although the mechanism by which ID4 expression is regulated in GBM tissues is unknown, preliminary work in our laboratory indicates that ID4 mRNA levels are enhanced by hypoxia, and hypoxia has been shown by others to regulate ID2 (Lofstedt et al., 2004) , a closely related protein.
As GBM have been widely documented as very hypoxic 
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PM Kuzontkoski et al tumors (Kleihues and Cavenee, 1997) , it is possible that the highly elevated ID4 levels we observed in GBM tumors are the result of hypoxia. When xenografts of U87-and U251-derived cultures expressing elevated ID4 grew larger than controls, we sought to characterize the mechanism by which ID4 promoted their growth. We could not find evidence that ID4 affected either apoptosis or the growth of U87-derived cultures. We did, however, observe that xenografts with elevated levels of ID4 were much more extensively vascularized than the corresponding, control xenografts (Figure 4 ). ID1 and ID3 are ID family members that have earlier been shown to regulate and enhance blood vessel growth (Lyden et al., 1999; Benezra et al., 2001) . They contribute to both developmental and tumor angiogenesis (Lyden et al., 1999; Benezra, 2001 ). In addition, although wild-type mice bearing tumors die because of rapid tumor growth after injection of syngeneic lymphoma, Id1
À/À mice displayed very limited tumor growth (Lyden et al., 1999) . Histological examination of these xenografts revealed stunted, occluded vessels in the tumors of the Id1
animals followed by complete regression at 2 weeks, and continued good health for well over a year (Lyden et al., 1999) . Subsequent studies have confirmed the central function of ID1 and ID3 in tumor angiogenesis (Volpert et al., 2002; Sakurai et al., 2004; Ling et al., 2005) and their elevation in tumor endothelium, although the molecular mechanisms mediating these events are unknown.
To explore ID4-promoted growth and vascularization of GBM xenografts, we used microarray analysis to examine differential gene expression in U251 cell cultures engineered to express varying levels of ID4, and identified MGP as an ID4 target gene whose expression and associated biologies were consistent with promoting tumor angiogenesis (Chen et al., 1990; Levedakou et al., 1992) . MGP is a member of the vitamin K-dependent family of proteins, which includes prothrombin (Proudfoot and Shanahan, 2006) . MGP is a 14.2 kDa secreted protein first isolated from bone, which is expressed in a number of soft tissues, atherosclerosis, and vascular calcification (Newman et al., 2001; Vermeer, 2001; Proudfoot and Shanahan, 2006) . MGP is aberrantly expressed in a number of solid tumors, including GBM, although its function in tumorigenesis is undefined. Interestingly, the levels of MGP in brain tumors have been recognized to be highest in GBM, the most highly vascularized of the tumors studied.
Others have shown that MGP promotes the growth of BAECs, and that when MGP is present, these cells form enclosures, the basis of the endothelial tube-formation assay (Kubota et al., 1988; Bostrom et al., 2004) . We treated BAECs with media conditioned by GBM- ID4 elevates MGP promoting GBM growth PM Kuzontkoski et al derived cell cultures expressing elevated levels of ID4 and found that this media could enhance endothelial cell growth and tube formation (Figure 3 ). To examine whether MGP was the ID4 target gene contributing to the vascularization and enhanced growth of the GBM xenografts, we engineered stable, U251 cell cultures in which ID4 levels were elevated, but MGP levels were reduced (Figure 6a ). When these cultures were injected into mice, the resulting xenografts were smaller and more sparsely vascularized than the xenografts of the U251 cultures with higher levels of MGP (Figures 6b-d) . The finding of decreased tumor growth (Figure 6b ) and decreased angiogenesis (Figure 6d ) after inhibition of MGP in cells expressing high levels of ID4 provides strong evidence that the pro-angiogenic effect of ID4 in GBM is mediated by MGP. These data support a model in which elevated ID4 enhances MGP expression, which in turn enhances tumor angiogenesis.
The precise mechanism by which ID4 enhances MGP levels requires further study, although the simplest explanation may be that ID4 inhibits the transcription of a currently undefined inhibitor of MGP expression. A recent report from Fontemaggi et al. (2009) , however, provides strong evidence for the neo-angiogenic activity of ID4 being mediated through two pro-angiogenic cytokines, IL8 and GRO-a. Although MGP or extracellular factors that might regulate it have not been identified as a target of these cytokines, the putative regulation of MGP by these cytokines provides a plausible molecular mechanism by which MGP promotes angiogenesis in GBM. Although understanding the precise mechanism by which ID4 promotes angiogenesis remains an important area of investigation, our study clearly shows important functions for ID4 and MGP in tumor angiogenesis and identifies ID4 and MGP as potential drug targets for the treatment of GBM. Cell culture GBM cell lines A172, SF268, SF767, SKMG7, SNB44, SNB75, SW1088, U87, U118, U251, U399MG, and U563 were cultured in Dulbecco's Modified Eagle's Medium/10% fetal bovine serum/1% penicillin (10 000 units/ml)/streptomycin (10 000 mg/ml). Human astrocytes were from ScienCell Research Laboratories (Carlsbad, CA, USA). All cells were grown in 5% CO 2 at 37 1C, unless indicated. For culture in hypoxic conditions, cells were placed in a hypoxia chamber (Billups-Rothenberg, Del Mar, CA, USA) with a mixture of 94% N 2 , 5% CO 2 , and 1% O 2 . To prepare conditioned media, cultures were grown to confluence, the medium removed, and cells washed with PBS. Fresh medium was added to the cultures, and they were incubated for 3 days when medium was collected, clarified, and stored at À80 1C.
Materials and methods
Tissue samples
Apoptosis analysis
Apoptotic cell death was quantified using Guava Personal Cytometer, CytoSoft software and Guava Nexin kit as per the manufacturer's instructions (Guava Technologies, Inc., Hayward, CA, USA).
Tumor xenograft growth in immunosuppressed mice
Female, 4-6-week-old Nude-Foxn1 nu mice (Harlan, Indianapolis, IN, USA) were injected subcutaneously with 4 Â 10 6 cells in the flank. Tumor size was measured in three dimensions with calipers, and volume was calculated assuming the shape as ellipsoid. All animal studies were conducted using procedures outlined by the Association for Assessment and Accreditation of Laboratory Animal Care and the Institutional Animal Care and Use Committee.
MicroCT evaluation of tumor vasculature
To image tumor vasculature, mice were anesthetized [ketamine (80 mg/kg)/xylazine (10 mg/kg)] and heparinized. A needle was inserted into the descending aorta for injection and the inferior vena cava was cut to allow drainage. Animals were then perfused with PBS until all blood was flushed and Microfil MV-122 Yellow was infused until the infusate flowed freely and all organs had a rich yellow coloration. Infused animals were chilled to enhance Microfil polymerization. Tumors were scanned using a GE eXplore Locus SP micro-CT scanner at 55 kV and 120 mA. The X-ray exposure was 1700 ms per projection and 720 projections/scan were acquired at maximum resolution, 6.5 mm. Three-dimensional images were reconstructed from the acquired two-dimensional projections by averaging every two neighboring pixels, a voxel size of 13 mm.
Plasmids for RNA expression of complementary DNA We cloned human ID4 complementary DNA (cDNA) into the pCbS-FLAG vector, confirmed the sequence of the entire coding region, and used this expression plasmid, pLHCX-FLAG-hID4. HuSHt shRNA constructs complementary to ID4 and MGP were obtained from Origene Technologies.
Transient expression and derivation of stable, polyclonal cultures expressing transgenes GBM-derived cell lines were transfected with expression plasmids using FuGENE 6 Transfection Reagent (Roche Molecular Biochemicals, Indianapolis, IN, USA) as per the manufacturer's instructions. Cells transfected with the pLHCX or pLHCX-FLAG-hID4 plasmid were selected for 4 weeks (or until no further cell death was observed) with hygromycin (U87: 80 mg/ml; U251: 110 mg/ml). Cells transfected with pRS::shRNA expression vectors were selected for approximately two and a half weeks (or until no further cell death was observed) with puromycin (SW1088: 0.25 mg/ml; U251::ID4 stable cultures: 1.0 mg/ml).
RNA and cDNA preparation RNA was isolated as described earlier (Havrda et al., 2008) . The cDNA was generated using iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA, USA) as per manufacturer's instructions. (Havrda et al., 2008) . This primary antibody was replaced by a pre-immune serum in controls. Biotinylated rabbit anti-rat, mouse-adsorbed antibody (Vector Laboratories, Inc., Burlingame, CA, USA), and biotinylated goat anti-rabbit antibody (Santa Cruz Biotechnology) were used at 1:250 and 1:300 dilutions as secondary antibodies for MECA and ID4, respectively.
Quantification of blood vessel area in histologic sections of tumor Paraffin-embedded xenograft sections were evaluated for MECA expression as described above to identify blood vessels. Photographs of the tumor periphery catalogued all superficial blood vessels. Using Adobe Photoshop (Adobe Systems, Inc., Mountain View, CA, USA), the vessels were outlined and filled in with black. Using Scion Image software (Scion, Frederick, MD, USA), we converted these images to binary files and for each image, quantified the area covered by black pixels (Supplementary Figure S2) . Five different xenografts were examined for each tumor genotype evaluated.
BAEC tube-formation assay with collagen-I overlay BAECs were cultured in 50% BAEC medium and 50% medium conditioned by various GBM-derived cell lines for 2 days before seeding. Collagen-I ( Â 2), 'PureCol,' from INAMED Biomaterials, Fremont, CA, USA, was diluted on ice 1:2 with chilled DMEM to a final concentration of 1.5 mg/ ml at pH 7.0. This preparation (1 ml) was added to a six-well plate to coat the bottom of the wells and allowed to polymerize for at least 1 h at 37 1C. BAECs (1 Â 10 5 ) were suspended in 200 ml medium, seeded as one drop to the center of each well, and incubated overnight. The medium was aspirated from the attached cells and a second layer of fresh, liquid collagen (1.5 ml) was added and allowed to polymerize for 1 h at 37 1C. Medium (2 ml) was added to each well, and one half was refreshed daily. BAECs were cultured for 6 days. Nine representative photographs ( Â 10) were taken daily in designated areas of each well. For all data points, three different observers counted blindly. BAEC enclosures in four wells (nine photographs each) were examined on day 5 for each type of conditioned media. These counts were averaged to derive mean enclosures per well (Supplementary Figure 2) .
Statistical analysis
Data are represented as the mean ± s.d. or ± s.e. as indicated. Differences were analyzed by a two-tailed, Student's t-test and Po0.05 was considered statistically significant. The correlation between ID4 and MGP expression in 12, independent, GBM-derived, stable, polyclonal cultures was derived by linear regression analysis.
